A Cautiously Optimistic Metric for Patients Undergoing Durable Left Ventricular Assist Device Implantation.
暂无分享,去创建一个
[1] F. Pagani,et al. Association of Days Alive and Out of the Hospital After Ventricular Assist Device Implantation With Adverse Events and Quality of Life. , 2023, JAMA surgery.
[2] N. Uriel,et al. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. , 2022, JAMA.
[3] N. Stockbridge,et al. Days Alive Out of Hospital in Heart Failure: Insights from the PARADIGM-HF and CHARM Trials. , 2021, American heart journal.
[4] N. Desai,et al. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy. , 2021, JACC. Heart failure.
[5] Josef Stehlik,et al. The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The Changing Landscape of Devices and Indications. , 2020, The Annals of thoracic surgery.
[6] P. Armstrong,et al. Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes , 2018, Circulation. Cardiovascular quality and outcomes.